![PRD_002489 PRD_002489](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002489.svg) | PRD_002489 | Name: | lipid II mimetic, LPATA: Thr-in conformation | Formula: | C53 H85 N14 O16 | Definition date: | 2022-09-07 | Last modified: | 2023-11-03 |
|
![PRD_000180 PRD_000180](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000180.svg) | PRD_000180 | Name: | Antipain | Formula: | C27 H46 N10 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000183 PRD_000183](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000183.svg) | PRD_000183 | Name: | Microcin C7 | Formula: | C28 H49 N12 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_002510 PRD_002510](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002510.svg) | PRD_002510 | Name: | Minihepcidin PR73 | Formula: | C86 H136 N21 O15 S | Definition date: | 2022-12-07 | Last modified: | 2023-11-03 |
|
![PRD_000197 PRD_000197](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000197.svg) | PRD_000197 | Name: | ALPHA LICHENICIDIN PREPEPTIDE | Formula: | C142 H226 N36 O41 S5 | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000198 PRD_000198](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000198.svg) | PRD_000198 | Name: | BETA LICHENICIDIN PREPEPTIDE | Formula: | C133 H200 N36 O37 S4 | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000212 PRD_000212](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000212.svg) | PRD_000212 | Name: | Microcystin LR | Formula: | C49 H75 N10 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000213 PRD_000213](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000213.svg) | PRD_000213 | Name: | motuporin | Formula: | C40 H57 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000214 PRD_000214](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000214.svg) | PRD_000214 | Name: | NODULARIN-R | Formula: | C41 H61 N8 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000215 PRD_000215](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000215.svg) | PRD_000215 | Name: | DIHYDROMICROCYSTIN-LA | Formula: | C46 H69 N7 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000988 PRD_000988](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000988.svg) | PRD_000988 | Name: | N-benzoyl-L-norleucyl-6-ammonio-L-norleucyl-N~5~-[amino(iminio)methyl]-N-[(2S)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-ornithinamide | Formula: | C31 H57 N11 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000224 PRD_000224](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000224.svg) | PRD_000224 | Name: | Polytheonamide B | Formula: | C219 H376 N60 O72 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001016 PRD_001016](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001016.svg) | PRD_001016 | Name: | Glidobactin | Formula: | C27 H46 N4 O6 | Definition date: | 2013-02-06 | Last modified: | 2023-11-03 |
|
![PRD_001018 PRD_001018](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001018.svg) | PRD_001018 | Name: | Cepafungin I | Formula: | C28 H48 N4 O6 | Definition date: | 2013-02-06 | Last modified: | 2023-11-03 |
|
![PRD_001021 PRD_001021](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001021.svg) | PRD_001021 | Name: | INHIBITOR ARC-670 | Formula: | C53 H103 N31 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001022 PRD_001022](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001022.svg) | PRD_001022 | Name: | (2S,5S,8S,13S,16Z)-5-benzyl-2-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxylic acid | Formula: | C36 H46 N8 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001023 PRD_001023](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001023.svg) | PRD_001023 | Name: | (2S,5S,8S,13S,16Z)-5-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-2-(3-phenylprop-2-en-1-yl)-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxamide | Formula: | C38 H49 N9 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001025 PRD_001025](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001025.svg) | PRD_001025 | Name: | Trypsin inhibitor 1 | Formula: | C67 H107 N18 O19 S2 | Definition date: | 2013-10-09 | Last modified: | 2023-11-03 |
|
![PRD_001031 PRD_001031](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001031.svg) | PRD_001031 | Name: | Microcystin-LR (MCLR) bound form | Formula: | C49 H77 N10 O12 | Definition date: | 2013-05-08 | Last modified: | 2023-11-03 |
|
![PRD_001041 PRD_001041](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001041.svg) | PRD_001041 | Name: | TMC-95A mimic ligand yCP:4e | Formula: | C61 H83 N9 O10 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001044 PRD_001044](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001044.svg) | PRD_001044 | Name: | TMC-95A mimic ligand yCP:3a | Formula: | C60 H80 N8 O11 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001047 PRD_001047](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001047.svg) | PRD_001047 | Name: | (2E,4E)-N-[(2R,3S)-1-{[(5S,8S,9E)-2,7-dioxo-5-(propan-2-yl)-1,6-diazacyclododec-9-en-8-yl]amino}-3-hydroxy-1-oxobutan-2-yl]dodeca-2,4-dienamide | Formula: | C29 H48 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001049 PRD_001049](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001049.svg) | PRD_001049 | Name: | TMC-95A mimic ligand yCP:4a chain Q | Formula: | C55 H72 N8 O9 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001066 PRD_001066](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001066.svg) | PRD_001066 | Name: | Muramyl tetrapeptide | Formula: | C30 H53 N8 O13 | Definition date: | 2014-03-12 | Last modified: | 2023-11-03 |
|
![PRD_001069 PRD_001069](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001069.svg) | PRD_001069 | Name: | N-acetyl-L-alanyl-L-alanyl-N-[(2S)-1-hydroxypropan-2-yl]-L-prolinamide | Formula: | C16 H28 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|